Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: December 3, 2021

DrugPatentWatch Database Preview

Patent: 9,284,556

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 9,284,556
Title:Methods for the treatment of hepatitis B and hepatitis D infections
Abstract: It is disclosed a method for the treatment of hepatitis B (HBV) infection or HBV/hepatitis D (HDV) co-infection, the method comprising administering to a subject in need of treatment a first pharmaceutically acceptable agent that removes the hepatitis B surface antigen from the blood and a second pharmaceutically acceptable agent which stimulates immune function.
Inventor(s): Bazinet; Michel (Montreal, CA), Vaillant; Andrew (Roxboro, CA)
Application Number:14/449,174
Patent Claims:see list of patent claims

Details for Patent 9,284,556

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Bayer Healthcare Pharmaceuticals Inc. BETASERON interferon beta-1b For Injection 103471 1993-07-23 ⤷  Try it Free 2032-08-30
Biogen Inc. AVONEX interferon beta-1a For Injection 103628 1996-05-17 ⤷  Try it Free 2032-08-30
Biogen Inc. AVONEX interferon beta-1a Injection 103628 2003-05-28 ⤷  Try it Free 2032-08-30
Biogen Inc. AVONEX interferon beta-1a Injection 103628 2012-02-27 ⤷  Try it Free 2032-08-30
Emd Serono, Inc. REBIF interferon beta-1a Injection 103780 2002-03-07 ⤷  Try it Free 2032-08-30
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.